Researcher profile

Minh Chau

Minh Chau contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 11 - UnverifiedVerification L1Unclaimed author
1works
0followers
1topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2026arXiv

A Sparse-Attention Deep Learning Model Integrating Heterogeneous Multimodal Features for Parkinson's Disease Severity Profiling

Characterising the heterogeneous presentation of Parkinson's disease (PD) requires integrating biological and clinical markers within a unified predictive framework. While multimodal data provide complementary information, many existing computational models struggle with interpretability, class imbalance, or effective fusion of high-dimensional imaging and tabular clinical features. To address these limitations, we propose the Class-Weighted Sparse-Attention Fusion Network (SAFN), an interpretable deep learning framework for robust multimodal profiling. SAFN integrates MRI cortical thickness, MRI volumetric measures, clinical assessments, and demographic variables using modality-specific encoders and a symmetric cross-attention mechanism that captures nonlinear interactions between imaging and clinical representations. A sparsity-constrained attention-gating fusion layer dynamically prioritises informative modalities, while a class-balanced focal loss (beta = 0.999, gamma = 1.5) mitigates dataset imbalance without synthetic oversampling. Evaluated on 703 participants (570 PD, 133 healthy controls) from the Parkinson's Progression Markers Initiative using subject-wise five-fold cross-validation, SAFN achieves an accuracy of 0.98 plus or minus 0.02 and a PR-AUC of 1.00 plus or minus 0.00, outperforming established machine learning and deep learning baselines. Interpretability analysis shows a clinically coherent decision process, with approximately 60 percent of predictive weight assigned to clinical assessments, consistent with Movement Disorder Society diagnostic principles. SAFN provides a reproducible and transparent multimodal modelling paradigm for computational profiling of neurodegenerative disease.